OUR TEAM
Management Team
Chief Executive Officer
Mr. Carlton is an experienced leader in the medical device industry. In addition to his role as CEO at EBT Medical, he is Co-founder and General Partner at Guide Medical Ventures, a seed investment and management consulting firm focusing on companies in the medical device space. Prior to his role at EBT Medical, he was President and CEO of HUINNO Inc., a digital healthcare company focused on improving the management and cost of hypertension through wearable technology and software.
Mr. Carlton came to Boston Scientific via the acquisition of Intelect Medical, where he served as both Co-Founder and Vice President of Product Development. While at Boston Scientific Neuromodulation, Mr. Carlton held multiple positions including Director of New Therapy Development where he focused on pain, deep brain stimulation, overactive bladder, and more.
At the start of his career, he held various roles at Medtronic, co-inventing the InterStim™ tined lead and developing InterStim™ II for the treatment of overactive bladder. He also served as Director of Engineering at Texcel Medical (Cirtec Medical).
Holding over 50 patents around electrical stimulations products and therapies, Mr. Carlton has a dual BS in Biomedical Engineering and Engineering Mechanics from The John Hopkins University. He also holds an MBA from Boston University.
Professor Yoo has spent nearly 3 decades researching diverse areas of peripheral nerve stimulation therapies, such as neural control of lower urinary function, obstructive sleep apnea, and chronic heart failure.
In addition to academic research, Dr. Yoo has worked on a number of projects within the medical device space working with such companies as Imthera Medical Inc, Microtransponder Inc., Ethicon Endosurgery, Boston Scientific Corporation, and Nuviant Medical.
Prior to joining the University of Toronto in 2012, Dr. Yoo worked both as a post-doctoral research associate and assistant research professor at Duke University under Warren Grill. Dr. Yoo received his BASc from the University of Toronto in Engineering Science (Biomedical Option), MS in Biomedical Engineering from the University of Southern California, and PhD from Case Western Reserve University in Biomedical Engineering.
Co-Founder, President, and Chief Scientific Officer
Co-Founder and Chief Innovation Officer
Dr. John is an inventor, scientist, and entrepreneur with 35+ years of experience developing and commercializing innovative medical and computer technologies. He is the sole inventor on the first patents for statistical, closed-loop neurostimulation (licensed into NeuroPace’s FDA-approved epilepsy therapy), and a co-inventor of an EEG-based audiometry technology acquired by Bio-logic Systems Corp. that became the company’s best-selling product prior to its acquisition by Natus.
He holds over 130 U.S. patents and has advised on IP strategy in areas of implantable and transcranial neurostimulation, neurodiagnostics, digital health, wireless power transmission, and renal nerve ablation. As Chief Scientific Officer of Avertix Medical, he helped secure FDA approval for the world’s first implantable heart-attack detector and led initiatives in clinical trial design and market access strategy. He received a B.A. in Psychology from Reed College, an M.Sc. in Psychiatry from McGill University, and a Ph.D. in Medical Science from the University of Toronto.